The detailed analysis of the changes of murine dendritic cells (DCs) induced by thymic peptide: Pidotimod(PTD)

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 9, 2012, Pages 1250-1258

  Hu, Xiaofang ^a   Zheng, Wei ^a   Wang, Lu ^a   Wan, Nan ^a   Wang, Bing ^a   Li, Weiwei ^b   Hua, Hui ^b   Hu, Xu ^b   Shan, Fengping ^b  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Dendritic cells; Immunomodulation; Maturation; Phagocytosis; Pidotimod

Indexed keywords

ACID PHOSPHATASE; B7 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 23; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PIDOTIMOD; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CELL ACTIVITY; CELL LINE; CELL MATURATION; CELL PHAGOCYTOSIS; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME REGULATION; FEMALE; IMMUNOMODULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-12; MICE; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; PYRROLIDONECARBOXYLIC ACID; THIAZOLIDINES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866980314     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.20579     Document Type: Article

References (33)

1. de la Torre González C, Pacheco Ríos A, Escalante Domínguez AJ, del Río Navarro BE. [Comparative meta-analysis of immunoestimulant agents used in pediatric patients in Mexico]. Rev Alerg Mex 2005; 52:25-38; PMID:15957470.
2. Riboldi P, Gerosa M, Meroni PL. Pidotimod: a reappraisal. Int J Immunopathol Pharmacol. 2009;22(2):255-62.
3. immunosuppression. Arch Pharm Res 2008; 31:1153-9; PMID:18806958.
4. Riboldi P, Gerosa M, Meroni PL. Pidotimod: a reappraisal. Int J Immunopathol Pharmacol 2009; 22:255-62; PMID:19505378.
5. Du Xiao F, Jiang CZ, Wu CF, Won EK, Choung SY. Synergistic immunostimulatory effect of pidotimod and red ginseng acidic polysaccharide on humoral immunity of immunosuppressed mice. Pharmazie 2008; 63:904-8; PMID:19177908.
6. Zervoudis S, Iatrakis G, Peitsidis P, Peitsidou A, Papandonopolos L, Nikolopoulou MK, et al. Complementary treatment with oral pidotimod plus vitamin C after laser vaporization for female genital warts: a prospective study. J Med Life 2010; 3:286-8; PMID:20945819.
7. Di Renzo M, Pasqui AL, Bruni F, Saletti M, Bova G, Chiarion C, et al. The in vitro effect of Pidotimod on some immune functions in cancer patients. Immunopharmacol Immunotoxicol 1997; 19:37-51; PMID:9049658; http://dx.doi.org/ 10.3109/08923979709038532.
8. Taramelli D, Malabarba MG, Basilico N, Sala G, Mattina R, Cocuzza C. Effects of pidotimod on macrophage functions in methylprednisolone-treated mice. Arzneimittelforschung 1994; 44(12A):1425-30; PMID:7857336.
9. Lanzavecchia A, Sallusto F. Ralph M. Steinman 1943-2011. Cell 2011; 147:1216-7; PMID:22263224; http://dx.doi.org/10.1016/j.cell.2011.11.040.
10. Van Nuffel AM, Benteyn D, Wilgenhof S, Pierret L, Corthals J, Heirman C, et al. Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients. Mol Ther 2012; 20:1063-74; PMID:22371843; http://dx.doi.org/10.1038/mt.2012.11.
11. Liu J, Chen W, Meng J, Lu C, Wang E, Shan F. Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK). [Epub ahead of print]. Cancer Immunol Immunother 2012; PMID:22392190.
12. Shan FP, Xia YJ, Wang N, Meng JJ, Lu CL, Meng YM, et al. Functional modulation of the pathway between dendritic cells (DCs) and CD4+T cells by the neuropeptide: methionine enkephalin (MENK). Peptides 2011; 32:929-37; PMID:21335041; http://dx.doi.org/10.1016/j.peptides.2011.01.033.
13. Coquerelle C, Moser M. DC subsets in positive and negative regulation of immunity. Immunol Rev 2010; 234:317-34; PMID:20193028; http://dx.doi.org/10. 1111/j.0105-2896.2009.00887.x.
14. Goel CD, Govindaraj D, Singh BP, Farooque A, Kalra N, Arora N. Serine protease Per a 10 from Periplaneta americana bias dendritic cells towards type 2 by upregulating CD86 and low IL-12 secretions. Clin Exp Allergy 2012; 42:412-22; PMID:22356142; http://dx.doi.org/10.1111/j.1365-2222.2011.03937.x.
15. Giagulli C, Noerder M, Avolio M, Becker PD, Fiorentini S, Guzman CA, et al. Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level. Int Immunopharmacol 2009; 9:1366-73; PMID:19712757; http://dx.doi.org/10.1016/j.intimp.2009.08.010.
16. Zou YX, Meng JJ, Chen WN, Liu JL, Li X, Li WW, et al. Modulation of phenotypic and functional maturation of murine dendritic cells (DCs) by purified Achyranthes bidentata polysaccharide (ABP). Int Immunopharmacol 2011; 11:1103-8; PMID:21439398; http://dx.doi.org/10.1016/j.intimp.2011.03.006.
17. Benetti GP, Illeni MT, Passera A, Bombelli G, Lavecchia G, Uslenghi C. Ex vivo evaluation of pidotimod activity in patients with chronic obstructive pulmonary disease. Arzneimittelforschung 1994; 44(12A):1503-5; PMID:7857352.
18. Chiarenza A, Iurato MP, Barbera N, Lempereur L, Cantarella G, Scapagnini U, et al. Effects of pidotimod on the immune and the neuroendocrine system in the aging rat. Arzneimittelforschung 1994; 44(12A):1437-40; PMID:7857338.
19. Guerra B, Perino A, Polatti F, Scala M. Pidotimod in the management of vulvar papillomatosis: double-blind clinical trial versus placebo. Am J Ther 1998; 5:147-52; PMID:10099052; http://dx.doi.org/10.1097/00045391-199805000- 00004.
20. Rodríguez Orozco AR. [Therapy with cytokines and thymic factors in a complicated case of common variable immunodeficiency]. Rev Alerg Mex 2003; 50:198-200; PMID:14631592.
21. Dianzani C, Colangelo D, Tonso E, Guidotto S, Viano I. In vivo antiviral effects of pidotimod. Arzneimittelforschung 1994; 44(12A):1431-3; PMID:7857337.
22. Auteri A, Pasqui AL, Bruni F, Saletti M, Di Renzo M, Bova G. Effect of Pidotimod, a new immunostimulating agent, on some aspects of immune response. In vitro study. Pharmacol Res 1992; 26(Suppl 2):196-7; PMID:1409308; http://dx.doi.org/10.1016/1043-6618(92)90662-U.
23. Borghi MO, Minonzio F, Fain C, Carbonelli V, Barcellini W, Del Papa N, et al. [Effect of pidotimod on the function of the human immune system: in vitro and ex vivo study]. Drugs Exp Clin Res 1993; 19(Suppl):37-43; PMID:8625781.
24. Burgio GR, Marseglia GL, Severi F, De Benedetti F, Masarone M, Ottolenghi A, et al. Immunoactivation by pidotimod in children with recurrent respiratory infections. Arzneimittelforschung 1994; 44(12A):1525-9; PMID:7857357.
25. Chiarenza A, Iurato MP, Barbera N, Lempereur L, Cantarella G, Scapagnini U, et al. Modulating effects of the synthetic thymic dipeptide pidotimod on the immune system in the aging rat. Pharmacol Toxicol 1994; 74:262-6; PMID:8090697; http://dx.doi.org/10.1111/j.1600-0773.1994.tb01109.x.
26. di Marco R, Condorelli F, Girardello R, Uslenghi C, Chisari G, di Mauro M, et al. Increased rate of survival in Streptococcus pneumoniae-infected rats treated with the new immunomodulator Pidotimod. Scand J Infect Dis 1992; 24:821-3; PMID:1287821; http://dx.doi.org/10.3109/00365549209062473.
27. Qi X, Wang L, Zhu J. Water-in-oil-in-water double emulsions: an excellent delivery system for improving the oral bioavailability of pidotimod in rats. J Pharm Sci 2011; 100:2203-11; PMID:21491444; http://dx.doi.org/10.1002/jps.22443.
28. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176:1693-702; PMID:1460426; http://dx.doi.org/10.1084/jem.176.6.1693.
29. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997; 158:2723-30; PMID:9058806.
30. Gourgiotis D, Papadopoulos NG, Bossios A, Zamanis P, Saxoni-Papageorgiou P. Immune modulator pidotimod decreases the in vitro expression of CD30 in peripheral blood mononuclear cells of atopic asthmatic and normal children. J Asthma 2004; 41:285-7; PMID:15260461; http://dx.doi.org/10.1081/JAS-120026085.
31. Meng JJ, Hu XF, Shan FP, Hua H, Lu CL, Wang EH, et al. Analysis of maturation of murine dendritic cells (DCs) induced by purified Ganoderma lucidum polysaccharides (GLPs). [Epub ahead of print]. Int J Biol Macromol 2011; 49:693-9; PMID:21763719; http://dx.doi.org/10.1016/j.ijbiomac.2011.06.029.
32. Migliorati G, Nicoletti I, Delfino D, Maggioni A, Coppi G, Riccardi C. [Pidotimod causes apoptotic cell death and inhibits the proliferative activity of YAC-1 tumor cells in vitro]. Drugs Exp Clin Res 1993; 19(Suppl):1-7; PMID:8625777.
33. Suen JL, Wu CH, Chen YY, Wu WM, Chiang BL. Characterization of self-T-cell response and antigenic determinants of U1A protein with bone marrow-derived dendritic cells in NZB x NZW F1 mice. Immunology 2001; 103:301-9; PMID:11454059; http://dx.doi.org/10.1046/j.1365-2567.2001.01255.x.